Plan to buy COVID-19 pills unchanged despite lower efficacy: CECC

Taiwan's plan to procure the oral antiviral drug, molnupiravir, remains unchanged, Health and Welfare Minister Chen Shih-chung (陳時中) said Saturday, although the drug has been shown to be less effective in reducing COVID-19 hospitalizations and deaths in its final analysis.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)